AzTrials
AzTrials

Postoperative PainNCT07440940

Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy

A study testing Ultrasound-guided subcostal TAP block combined with rectus sheath block in people with Postoperative Pain and Laparoscopic Cholecystectomy, run by Eulji University Hospital at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective randomized controlled trial aims to evaluate whether the timing of ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) affects postoperative pain in patients undergoing laparoscopic cholecystectomy. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Ultrasound-guided subcostal TAP block combined with rectus sheath block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteSouth Korea
Study dates
23 Feb 2026to 15 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective laparoscopic cholecystectomy
  • Adults aged 18 to 80 years
  • Ability to understand the study procedures and provide informed consent
  • American Society of Anesthesiologists (ASA) physical status I-III

Who cannot join

  • Presence of significant pain unrelated to the target disease that may interfere with pain assessment
  • Known allergy or contraindication to study medications (ropivacaine, acetaminophen, nefopam, or pethidine)
  • Planned single-port laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status IV or higher
  • Infection of the abdominal wall or skin at the injection site, or anatomical abnormalities of the abdominal wall
  • Major neurological, psychiatric, or systemic diseases that may affect pain perception, treatment response, or study evaluation
Show all 10Show fewer
  • Requirement for postoperative mechanical ventilation
  • Pregnancy or breastfeeding
  • Considered unsuitable for the study by the investigator
  • Refusal to participate or inability to provide informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

South Korea1 site, 1 recruiting
  • Nowon Eulji University Hospital

    Seoul, 01830

    Hye-yeon Cho, MD, +82-2-970-8705, anesthesia_chy@eulji.ac.kr

    Recruiting

Other trials in South Korea

About this study

Official title: Effect of Timing of Ultrasound-Guided Subcostal Transversus Abdominis Plane Block Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial

This prospective randomized controlled trial aims to evaluate whether the timing of ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) affects postoperative pain in patients undergoing laparoscopic cholecystectomy.

Participants will be randomly assigned to receive the combined regional blocks either before surgical incision or after completion of surgery. The primary outcome is postoperative pain intensity measured using a numerical rating scale. Secondary outcomes include opioid consumption, incidence of postoperative nausea and vomiting, and other recovery parameters.

The results of this study may help optimize the timing of abdominal wall blocks to improve postoperative analgesia and recovery following laparoscopic cholecystectomy.

Read the detailed description

Postoperative pain after laparoscopic cholecystectomy remains a significant clinical concern despite the minimally invasive nature of the procedure. Ultrasound-guided abdominal wall blocks, including subcostal transversus abdominis plane (TAP) block and rectus sheath block (RSB), are widely used to reduce postoperative pain and opioid requirements. However, the optimal timing of block administration relative to surgical incision remains unclear.

This prospective, single-center, randomized controlled trial will compare the analgesic efficacy of pre-incisional versus post-operative administration of combined ultrasound-guided subcostal TAP block and RSB in adult patients undergoing elective laparoscopic cholecystectomy under general anesthesia.

Participants will be randomized in a 1:1 ratio using block randomization with randomly permuted block sizes. Standardized general anesthesia and postoperative analgesia protocols will be applied to all participants.

The primary outcome will be postoperative pain intensity measured using a numerical rating scale at predefined time points after surgery. Secondary outcomes will include cumulative opioid consumption, incidence of postoperative nausea and vomiting, rescue analgesic requirements, and recovery profiles.

The findings of this study are expected to provide evidence for optimizing the timing of abdominal wall block administration to improve postoperative analgesia and patient recovery after laparoscopic cholecystectomy.

Being tested
Ultrasound-guided subcostal TAP block combined with rectus sheath block
Keywords
Laparoscopic Cholecystectomy, Transversus Abdominis Plane Block, Rectus Sheath Block, Postoperative pain
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided subcostal TAP block combined with rectus sheath blockProcedure or surgery

    Ultrasound-guided right subcostal transversus abdominis plane (TAP) block combined with bilateral rectus sheath block (RSB) is performed under sterile conditions using local anesthetic for postoperative analgesia.

Study groups in NCT07440940
Study groupRoleWhat they receive
Pre-incisional Block GroupExperimentalParticipants receive ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) after induction of general anesthesia and before surgical incision.
Receives: Procedure: Ultrasound-guided subcostal TAP block combined with rectus sheath block
Postoperative Block GroupExperimentalParticipants receive ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) after completion of surgery and before emergence from anesthesia.
Receives: Procedure: Ultrasound-guided subcostal TAP block combined with rectus sheath block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum postoperative pain intensity within 24 hours

    The highest postoperative pain intensity measured using an 11-point numeric rating scale (NRS; 0 = no pain, 10 = worst pain imaginable) during the first 24 hours after surgery, assessed at 1, 6, 12, and 24 hours postoperatively.

    Measured: Within 24 hours after surgery

Secondary outcomes (3)
  1. Maximum postoperative pain intensity during post-anesthesia care unit stay

    The highest postoperative pain intensity measured using an 11-point numeric rating scale (NRS; 0 = no pain, 10 = worst pain imaginable) during the recovery period.

    Measured: During the post-anesthesia care unit stay

  2. Cumulative rescue opioid consumption within 24 hours

    Total amount of rescue opioid administered between 1 and 24 hours after surgery.

    Measured: Within 24 hours after surgery

  3. Incidence of postoperative nausea and vomiting

    Occurrence of nausea or vomiting during the postoperative period.

    Measured: Within 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study start23 Feb 2026
  3. Primary completion15 Jan 2027 (estimated)
  4. Study completion15 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to receive the combined ultrasound-guided subcostal TAP block and rectus sheath block either before surgical incision or after completion of surgery.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07440940
Sponsor's protocol ID
2026-01-026
Status last verified
Feb 2026
First submitted
22 Feb 2026
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound-guided subcostal TAP block combined with rectus sheath block in people with Postoperative Pain and Laparoscopic Cholecystectomy, run by Eulji University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hye-Yeon Cho, MD (+82-2-970-8705, anesthesia_chy@eulji.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum postoperative pain intensity within 24 hours (time frame: Within 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in